Hangzhou Biotest Biotech Co.,Ltd.
SSE:688767.SS
32.14 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| 166.775 | 106.606 | 773.584 | 835.756 | 434.966 | 27.935 | 18.853 | 3.355 |
| Depreciation & Amortization
| 22.616 | 29.173 | 23.251 | 10.534 | 5.484 | 4.949 | 4.159 | 3.362 |
| Deferred Income Tax
| 0 | 0 | -9.008 | -1.486 | -0.429 | -0.092 | -0.01 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -77.805 | -49.877 | -49.044 | 31.322 | -22.991 | -10.334 | -9.295 | -4.974 |
| Accounts Receivables
| -39.776 | -13.569 | 107.835 | -51.4 | -69.62 | -14.418 | -7.647 | -2.777 |
| Inventory
| 3.129 | -14.143 | -48.931 | -60.843 | -60.891 | -3.719 | -11.332 | -2.967 |
| Accounts Payables
| 0 | -20.427 | -98.94 | 145.052 | 107.949 | 7.894 | 9.694 | 0 |
| Other Working Capital
| -41.158 | -1.739 | -9.008 | -1.486 | -0.429 | -0.092 | 2.037 | -2.008 |
| Other Non Cash Items
| 17.238 | 45.479 | -44.579 | 30.512 | 28.606 | 3.117 | 7.452 | 5.33 |
| Operating Cash Flow
| 128.825 | 131.381 | 703.212 | 908.123 | 446.066 | 25.667 | 21.169 | 7.073 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -245.055 | -56.424 | -178.918 | -200.198 | -57.682 | -39.472 | -12.667 | -26.369 |
| Acquisitions Net
| 0 | 0.182 | -0 | 399.773 | 1.536 | 0 | 0.055 | -6.243 |
| Purchases Of Investments
| -6,993.774 | -3.8 | -290 | -400 | -50 | 0 | 0 | -0 |
| Sales Maturities Of Investments
| 6,400.497 | 130.565 | 565.631 | 0.227 | 50.13 | 0 | 0 | 16.11 |
| Other Investing Activites
| 0.081 | 3.839 | 275.631 | -399.773 | -0.061 | -39.472 | 0.055 | 1.122 |
| Investing Cash Flow
| -838.251 | 74.362 | 96.713 | -599.971 | -56.078 | -39.472 | -12.612 | -15.38 |
| Financing Activities: | ||||||||
| Debt Repayment
| -0.148 | 0.24 | -5.285 | -2.462 | -21.009 | 12.025 | -0.047 | 13.954 |
| Common Stock Issued
| 0 | 0 | 0 | 856.145 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -14.764 | 0 | -856.145 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -83.645 | -234.667 | -320 | -20.912 | -100.382 | -1.083 | -0.883 | -0.61 |
| Other Financing Activities
| -20.76 | -14.76 | -7.368 | 836.611 | -3.531 | -0.006 | -0.075 | -1.768 |
| Financing Cash Flow
| -104.553 | -249.187 | -332.653 | 813.237 | -124.922 | 10.936 | -1.006 | 11.576 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 10.5 | 10.894 | 104.906 | -14.824 | -17.703 | 0.34 | -0.118 | -0.6 |
| Net Change In Cash
| -803.479 | -32.55 | 572.177 | 1,106.565 | 247.363 | -2.529 | 7.433 | 2.669 |
| Cash At End Of Period
| 1,103.759 | 1,907.239 | 1,939.789 | 1,367.612 | 261.047 | 13.683 | 16.213 | 8.779 |